Vimarsana
Biggest News Aggregation in the World

Page 4 - Webcast Today News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Webcast Today. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Webcast Today Today - Breaking & Trending Today

Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Multiple data presentations upcoming at AASLD – The Liver Meeting®, including preliminary data from Phase 2a clinical trial combining imdusiran, our RNAi therapeutic, with VTP-300, an HBV...

Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Arbutus Biopharma (NASDAQ:ABUS) - Vimarsana News

Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Arbutus Biopharma (NASDAQ:ABUS)

Multiple data presentations upcoming at AASLD – The Liver Meeting®, including preliminary data from Phase 2a clinical trial combining imdusiran, our RNAi therapeutic, with VTP-300, an HBV antigen-specific

Exelixis Announces Third Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Exelixis Announces Third Quarter 2023 Financial Results and Provides Corporate Update

- Total Revenues of $471.9 million, Cabozantinib Franchise U.S. Net Product Revenues of $426.5 million -- Conference Call and Webcast Today at 5:00 PM Eastern Time -ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2023 and provided an update on...

Neurocrine Biosciences Reports Third Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance - Vimarsana News

Neurocrine Biosciences Reports Third Quarter 2023 Financial Results and Raises 2023 INGREZZA Sales Guidance

INGREZZA® (valbenazine) Third Quarter Net Product Sales of $486 Million Representing 29% Year-Over-Year GrowthINGREZZA® (valbenazine) 2023 Net Pro...

Perimeter Medical Imaging AI Reports Second Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Perimeter Medical Imaging AI Reports Second Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology...